Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
about
Gut Microbiota Modification: Another Piece in the Puzzle of the Benefits of Physical Exercise in Health?Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysisA randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and quality of life.A pilot study on the effect of a symbiotic mixture in irritable bowel syndrome: an open-label, partially controlled, 6-month extension of a previously published trial.Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection.Impact of genomics on the field of probiotic research: historical perspectives to modern paradigms.Amelioration of colitis in mouse model by exploring antioxidative potentials of an indigenous probiotic strain of Lactobacillus fermentum Lf1.Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome.Genomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health.Bloating and functional gastro-intestinal disorders: where are we and where are we going?Transcriptional analysis of prebiotic uptake and catabolism by Lactobacillus acidophilus NCFM.The effect of selected synbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon.Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysisEfficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.Pathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air?Probiotic and anti-inflammatory attributes of an isolate Lactobacillus helveticus NS8 from Mongolian fermented koumiss.Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating.Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysisLactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study.Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.S-layer protein mediates the stimulatory effect of Lactobacillus helveticus MIMLh5 on innate immunity.Oral administration of fermented milk supplemented with synbiotics can influence the physiological condition of Wistar rats in a dose-sensitive and sex-specific manner.Short term (14 days) consumption of insoluble wheat bran fibre-containing breakfast cereals improves subjective digestive feelings, general wellbeing and bowel function in a dose dependent mannerIntestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome.Modulation of anti-inflammatory response in lipopolysaccharide stimulated human THP-1 cell line and mouse model at gene expression level with indigenous putative probiotic lactobacilliIrritable bowel syndrome symptom severity improves equally with probiotic and placebo.Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis.Review article: probiotics for the treatment of irritable bowel syndrome--focus on lactic acid bacteria.Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome.Probiotics use to treat irritable bowel syndrome.Complementary and alternative medicine and mind-body therapies for treatment of irritable bowel syndrome in women.American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.Probiotic Formulations: Application and Status as Pharmaceuticals-A Review.An Extracellular Cell-Attached Pullulanase Confers Branched α-Glucan Utilization in Human Gut Lactobacillus acidophilus.Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial.Complete genome sequences of probiotic strains Bifidobacterium animalis subsp. lactis B420 and Bi-07.A randomized, double-blind, controlled study and pooled analysis of two identical trials of fermented milk containing probiotic Bifidobacterium lactis CNCM I-2494 in healthy women reporting minor digestive symptoms.Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.Effects of probiotic supplementation over 5 months on routine haematology and clinical chemistry measures in healthy active adults.
P2860
Q26765902-AD0B6552-F6B2-4FA5-8756-FD3CDE4DAD46Q28244815-8F6E6F25-1CA8-4473-919F-B0AB42AD3B02Q33455506-34CD3773-A5EA-4859-B2B2-55AB8E5045D4Q33458837-8F6BA783-E2C0-41C1-A9B5-795D5C8CD15EQ33458873-ABAAFA98-456F-409E-96A1-E4A6BBDBD897Q33780331-1CF1E751-E138-4A35-B518-922E99536498Q33908943-22BC0C64-1BC5-4F63-BFBE-D620056FA460Q33954221-FC8A9FEE-027B-4137-8F47-86ABDA137DC0Q34332869-0CD495FE-B9F1-46AC-AC4F-27BD48EA861EQ34366956-A800AEC3-D078-4C9A-9743-0C135636E60FQ34427074-273871BB-FE76-48DB-BD7C-4E2AA3A228EDQ34452017-00CB1446-F584-4E60-AF67-775D187F89E4Q35375748-27CC378B-4B58-4111-8553-6C73AF62591BQ35586987-E0379742-8B10-48F8-AC80-1D9C2321EA40Q35691226-4BD7ECC9-4E56-44CF-AB8E-D33721571BCAQ35795912-F01CE637-2155-47DD-961B-572DD7D40FD6Q35878015-76F0082D-5467-4417-955C-A36DE819B840Q36050769-0AD98B39-204F-406C-A193-C6B54A3D1D56Q36185519-57E0C7F8-3E16-4044-A372-73D11E976E97Q36211712-E33B07F2-3396-45A9-A123-385675CB2568Q36310200-7F54B383-0241-42DD-B221-726C89A6DE7EQ36599131-2092A06F-3016-4F96-9E3B-E5305FB27640Q36875924-337E206E-D075-4DDC-A2E4-95E1E3AB4FC4Q36994108-B5FE41E4-7C34-4C40-B6B0-19FDDE589D77Q37234770-CD512D9B-156E-4844-9AB6-F66E84573563Q37299999-05E8230B-07E1-4F84-BE0B-1A69C859ACD3Q37538949-B28B454B-2D1B-4D20-9884-9A8C3C794B5EQ37677017-0FA9DE83-754F-4E49-BC05-1B3F005E869CQ37973803-8BA0917B-7B10-467D-9640-984374812D29Q38014500-06AEB5C7-BAF5-4DCD-B3BB-5663CF4FD72BQ38035021-F305B0A2-12E9-42E2-A5B2-6B323E46DD18Q38155671-C25258E3-4E4B-445E-BF8D-FC994C55069DQ38236812-01865C79-C1F0-4730-9135-6F422137614FQ38702214-7BBDCE5A-AFE6-415A-A382-4A0AC72B25B0Q38836154-A2947EB6-D54E-4A2F-89F8-192A40AFE146Q39172677-F2BD3600-C1EB-47CF-B028-8698CA4913C3Q42131498-A08C6287-7084-4F2C-8436-FAEB1DE5E25FQ46116511-271D69D1-43A4-4428-B00B-51F9087AA66FQ46302916-891420F1-399F-4083-B170-C0DCECAAD0BEQ46317211-5812F45E-4F6B-481B-85DA-1661D25F49D7
P2860
Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Probiotic bacteria Lactobacill ...... sorders: a double-blind study.
@ast
Probiotic bacteria Lactobacill ...... sorders: a double-blind study.
@en
type
label
Probiotic bacteria Lactobacill ...... sorders: a double-blind study.
@ast
Probiotic bacteria Lactobacill ...... sorders: a double-blind study.
@en
prefLabel
Probiotic bacteria Lactobacill ...... sorders: a double-blind study.
@ast
Probiotic bacteria Lactobacill ...... sorders: a double-blind study.
@en
P2093
P2860
P1476
Probiotic bacteria Lactobacill ...... sorders: a double-blind study.
@en
P2093
Danielle Maier
Gregory Leyer
Ian Carroll
Joseph A Galanko
Olafur S Palsson
Tamar Ringel-Kulka
Yehuda Ringel
P2860
P304
P356
10.1097/MCG.0B013E31820CA4D6
P577
2011-07-01T00:00:00Z